These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2253054)

  • 21. Differential patterns of anti-tumour drug responses and mechanisms of resistance in a series of independently-derived VP-16-resistant human tumour cell lines.
    Lock RB; Hill BT
    Int J Cancer; 1988 Sep; 42(3):373-81. PubMed ID: 3417366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel selection and genetic characterisation of an etoposide-resistant human leukaemic CCRF-CEM cell line.
    Patel S; Fisher LM
    Br J Cancer; 1993 Mar; 67(3):456-63. PubMed ID: 8382508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoposide-resistant human colon and lung adenocarcinoma cell lines exhibit sensitivity to homoharringtonine.
    Wilkoff LJ; Dulmadge EA; Vasanthakumar G; Donahue JP
    Cancer Chemother Pharmacol; 1993; 33(2):149-53. PubMed ID: 8261574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression.
    Harker WG; Slade DL; Dalton WS; Meltzer PS; Trent JM
    Cancer Res; 1989 Aug; 49(16):4542-9. PubMed ID: 2568172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug resistance in human lung cancer cell lines: cross-resistance studies and effects of the calcium transport blocker, verapamil.
    Twentyman PR; Fox NE; Bleehen NM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1355-8. PubMed ID: 3019960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation.
    Whelan RD; Hill BT
    Breast Cancer Res Treat; 1993; 26(1):23-39. PubMed ID: 8400321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
    Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
    Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage.
    Ganapathi R; Grabowski D; Ford J; Heiss C; Kerrigan D; Pommier Y
    Cancer Commun; 1989; 1(4):217-24. PubMed ID: 2576973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
    Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells.
    McClean S; Hosking LK; Hill BT
    J Natl Cancer Inst; 1993 Jan; 85(1):48-53. PubMed ID: 8093217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug sensitivity of heat-resistant mouse B16 melanoma variants.
    Kroll DJ; Borgert CJ; Wiedmann TW; Rowe TC
    Radiat Res; 1990 Oct; 124(1):15-21. PubMed ID: 2236492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological control of P-glycoprotein expression].
    Muller C; Bailly JD; Jaffrezou JP; Goubin F; Laurent G
    Bull Cancer; 1994 May; 81(5):386-91. PubMed ID: 7749215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene.
    Fojo AT; Shen DW; Mickley LA; Pastan I; Gottesman MM
    J Clin Oncol; 1987 Dec; 5(12):1922-7. PubMed ID: 3681376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
    Ripple M; Mulcahy RT; Wilding G
    J Urol; 1993 Jul; 150(1):209-14. PubMed ID: 8510259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of three bleomycin-resistant human carcinoma cell lines and their cross-resistance to other antitumor agents.
    Urade M; Sugi M; Miyazaki T
    Cancer; 1988 Apr; 61(8):1501-7. PubMed ID: 2450630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
    Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
    Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.